Maternal-Fetal Medicine
Placental Abruption
Placental abruption is a clinical diagnosis requiring immediate assessment of maternal hemodynamics, coagulation, and fetal status. Vaginal blood loss may substantially underestimate severity; management prioritizes resuscitation, early recognition of consumptive coagulopathy, and delivery based on maternal and fetal condition.
Emergency recognition
When to suspect placental abruption
Treat suspected abruption as an obstetric hemorrhage and fetal-risk emergency until stability is established.
Placental abruption is premature placental separation before delivery and occurs in approximately 0.6% to 1.2% of pregnancies. Presentation ranges from recurrent light bleeding in chronic abruption to concealed hemorrhage, uterine hypertonus, fetal hypoxia, maternal shock, and DIC. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
Suspect abruption with new vaginal bleeding plus abdominal or back pain, uterine tenderness or hypertonus, frequent contractions/tachysystole, decreased fetal movement, nonreassuring fetal heart rate (FHR) findings, or trauma. Absence of vaginal bleeding does not exclude abruption because bleeding may be concealed. PubMed+2PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI BookshelfPubMedPlacental abruption
Risk is increased by prior abruption, chronic hypertension, preeclampsia, cigarette smoking, cocaine or other illicit drug exposure, PPROM, chorioamnionitis, fetal growth restriction, multifetal gestation, polyhydramnios or sudden uterine decompression, and abdominal trauma. Chronic hypertension confers a 3- to 4-fold higher risk and preeclampsia a 4- to 6-fold higher risk in the cited review. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
Assess immediately for maternal instability: tachycardia, hypotension, altered mental status, oliguria, or escalating pain/hypertonus. Compensated physiology and concealed bleeding can mask severity. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
For viable pregnancies, institute continuous electronic fetal monitoring after maternal stabilization is underway. Marked bradycardia, absent variability, recurrent late or variable decelerations, or sinusoidal pattern may accompany severe abruption. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI Bookshelf
Diagnosis
Diagnostic approach and limits of testing
No laboratory, imaging, or fetal-monitoring result independently confirms or excludes abruption.
Diagnosis integrates presentation, examination, fetal assessment, exclusion of placenta previa and other causes of antepartum bleeding, and postpartum placental findings when available. Do not delay resuscitation or indicated delivery to obtain imaging. PubMed+2PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI BookshelfPubMedPlacental abruption
Perform sterile speculum examination to evaluate bleeding and cervical source. If placental location is unknown, defer digital cervical examination until ultrasound has excluded placenta previa. PubMedPubMedPlacental Abruption - StatPearls - NCBI Bookshelf
Ultrasound is useful to determine placental location and may identify retroplacental, marginal, subchorionic, preplacental, or intraplacental collections. However, acute hemorrhage can be isoechoic to placenta. In one cited study, ultrasound sensitivity was 57.0% and negative predictive value 14.0%; another review reports high specificity but poor sensitivity. Thus, a negative scan must not provide reassurance when the clinical syndrome suggests abruption. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
Obtain CBC with platelet count; PT, aPTT, and fibrinogen; type and screen/crossmatch; and renal function. Repeat studies when bleeding, clinical status, or delivery risk warrants, because initial hemoglobin may be falsely reassuring in acute hemorrhage. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
Obtain Kleihauer-Betke testing for Rh(D)-negative patients with antepartum bleeding to guide Rh(D) immune globulin dosing; it does not diagnose abruption or determine its severity. PubMed+2PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI BookshelfPubMedPlacental abruption
Use ultrasound to exclude placenta previa and assess fetal viability, not to rule out abruption. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI Bookshelf
Maternal stabilization
Immediate management of suspected acute abruption
Resuscitation and delivery planning proceed in parallel.
Place the patient in a monitored obstetric setting, establish at least two large-bore IV lines, begin crystalloid resuscitation as needed, obtain blood samples and crossmatched blood, and activate obstetric anesthesia, neonatal, blood-bank, and operating-room resources early when hemorrhage or fetal compromise is suspected. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
The amount of external bleeding should not determine urgency. Maternal status, fetal status, ongoing bleeding, uterine tone, and laboratory trajectory should drive escalation. Severe hemorrhage, maternal cardiovascular instability, or both mandate immediate delivery regardless of gestational age or neonatal resources. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
At near-term and term gestations, acute abruption is generally managed with maternal stabilization followed by delivery. Intrauterine maneuvers may have limited benefit in acute severe abruption and must not delay delivery for persistent category III FHR patterns or maternal deterioration. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
Communicate concern for concealed hemorrhage and early DIC explicitly to anesthesia and the blood bank. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
Use serial vital signs, urine output, mental status, bleeding assessment, CBC, fibrinogen, and coagulation studies to track response. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
If available, TEG or ROTEM can provide results in approximately 15 to 20 minutes and may support goal-directed blood component therapy in major obstetric hemorrhage. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
Hemostatic resuscitation
Hemorrhage and DIC management
Abruption can cause rapid consumption of fibrinogen, platelets, and clotting factors.
Abruption is described as the most common cause of DIC in pregnancy. The classic pattern is thrombocytopenia, prolonged PT/aPTT, and hypofibrinogenemia, although fibrinogen may initially be normal or only mildly reduced because it is an acute-phase reactant in pregnancy. Early hypofibrinogenemia is particularly concerning in major obstetric hemorrhage. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
Give packed red blood cells according to active blood loss, hemodynamics, expected ongoing hemorrhage, and time to delivery rather than a static hemoglobin threshold in active bleeding. Fresh frozen plasma is appropriate for multiple acquired factor deficiencies, including DIC or massive transfusion. Cryoprecipitate provides concentrated fibrinogen for acquired hypofibrinogenemia. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
In the cited near-term and term review, cryoprecipitate was recommended to maintain fibrinogen above 50 to 100 mg/dL and platelets above 50,000/mL in active bleeding. A more recent anesthesia review emphasizes that fibrinogen below 2 g/L is inadequate for effective coagulation and predicts severe hemorrhage; institutional obstetric hemorrhage protocols should govern target selection and product dosing. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
Activate a massive transfusion protocol for uncontrolled or rapidly escalating hemorrhage; use uncrossmatched type O-negative blood when immediate transfusion is necessary. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
Repeat hemostatic assessment frequently during major hemorrhage; one review recommends every 30 minutes because coagulopathy can evolve rapidly. PubMedPubMedPlacental abruption
Warm blood products and prevent hypothermia, which worsens coagulopathy. PubMedPubMedPlacental abruption
Tranexamic acid is discussed in international obstetric hemorrhage guidance as 1 g IV over 10 minutes for hemorrhage exceeding 1,000 mL, with a second dose considered after 30 minutes if bleeding continues; use should follow local protocol and obstetric hemorrhage guidance. PubMedPubMedPlacental abruption
Obstetric management
Delivery route and timing
The decision is driven by maternal stability, fetal status, labor progress, and the risks of operative bleeding.
For acute abruption, severe hemorrhage or maternal instability requires immediate delivery. A viable fetus with severe FHR compromise generally requires emergent cesarean delivery unless vaginal delivery is imminent. With reassuring fetal status and maternal stability, delivery route can be individualized; vaginal birth may be appropriate when labor is progressing and can be safely completed. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
If fetal death has occurred, vaginal delivery is preferred in most cases because cesarean delivery increases surgical hemorrhage risk in a setting predisposed to DIC and may add future uterine scar morbidity. Cesarean delivery may still be required for maternal indications, contraindication to vaginal delivery, or individualized concern for uterine rupture. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
Chronic abruption has limited evidence for optimal timing. Following inpatient observation, selected stable preterm patients may be managed outpatient if they can comply with surveillance. The cited review recommends once- or twice-weekly antenatal surveillance from diagnosis, serial growth assessment, and Dopplers when fetal growth restriction or fetal anemia is suspected. Delivery during 36 to 37 weeks is presented as expert opinion, with earlier delivery for ongoing bleeding, FHR abnormalities, oligohydramnios, or growth restriction. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
Do not delay indicated late-preterm delivery to complete antenatal corticosteroids in acute abruption. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
The cited near-term/term review advises against tocolysis in the 34 0/7 to 36 6/7 week interval for abruption. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
For preeclampsia with severe features accompanying abruption, use magnesium sulfate for seizure prophylaxis as appropriate; this is distinct from fetal neuroprotection use. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
| Clinical scenario | Recommended direction |
|---|---|
| Severe hemorrhage or maternal cardiovascular instability | Immediate delivery after/while initiating maternal resuscitation, regardless of gestational age. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption |
| Viable fetus with severe FHR compromise | Emergent cesarean delivery unless vaginal birth is imminent. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption |
| Maternal and fetal stability with progressing labor | Vaginal delivery may be reasonable with continuous reassessment and ability to proceed to cesarean delivery if status changes. PubMedPubMedPlacental abruption |
| Fetal demise | Vaginal delivery is generally preferred; individualize if maternal condition or obstetric factors require surgery. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption |
| Stable chronic abruption before term | Observation followed by individualized surveillance and planned delivery; limited evidence supports exact timing. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management |
Periprocedural care
Anesthesia and post-delivery monitoring
Abruption-associated coagulopathy changes both anesthetic and postpartum risk.
Neuraxial anesthesia may be feasible in a normovolemic, cardiovascularly stable patient without clinically significant coagulopathy, but abruption can produce rapidly evolving coagulopathy. Coagulation assessment and correction are necessary before neuraxial catheter removal. General anesthesia is indicated with major hemorrhage or instability. PubMedPubMedPlacental abruption
After delivery, monitor closely for recurrent hemorrhage, uterine atony, persistent coagulopathy, renal injury, and complications of major transfusion. Patients with major hemorrhage or DIC may require higher-acuity postpartum monitoring or intensive care. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
Placental pathology can support retrospective diagnosis but cannot direct initial management. Placental examination may show an adherent retroplacental clot or decidual hemorrhage with placental indentation; acute and chronic cases can have nonspecific findings. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
Counseling
Recurrence, outcomes, and future pregnancy planning
Abruption identifies both recurrence risk and longer-term vascular risk.
A history of abruption confers up to a 10-fold increased recurrence risk in a subsequent pregnancy; risk is reported as 25-fold higher after two prior affected pregnancies. In another cited review, recurrence is reported as 4% to 12%. Counseling should therefore include early prenatal risk assessment and attention to modifiable contributors, especially smoking, cocaine or other illicit drug use, and hypertension control. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI Bookshelf
Maternal short-term risks include hemorrhagic shock, DIC, transfusion, hysterectomy, renal failure, ICU admission, and death. Perinatal risks include fetal hypoxia, stillbirth, preterm birth, and fetal growth restriction. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI Bookshelf
A systematic review and meta-analysis cited in the near-term/term review found a 2.65-fold higher risk of combined cardiovascular and stroke mortality after abruption. This association supports communication of abruption history to longitudinal primary care and cardiovascular clinicians, while recognizing that causal pathways and optimal preventive interventions are not established by the cited literature. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
Document the abruption phenotype, gestational age, severity, fetal outcome, transfusion/coagulopathy, placental pathology, and potentially modifiable risk factors to guide future pregnancy counseling. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI Bookshelf
Address tobacco cessation, substance-use treatment, and hypertension management before and during a subsequent pregnancy. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI Bookshelf
Common questions
Can ultrasound rule out placental abruption?
No. Ultrasound can identify placental location and some hematomas, but acute blood may be isoechoic to placenta. A negative ultrasound does not exclude clinical or concealed abruption. PubMed+2PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI BookshelfPubMedPlacental abruption
What laboratory tests should be ordered immediately when abruption is suspected?
Order CBC with platelet count, PT, aPTT, fibrinogen, type and screen/crossmatch, and renal function. Repeat testing based on bleeding and clinical trajectory; initial hemoglobin may not reflect acute concealed blood loss. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
When is cesarean delivery indicated in placental abruption?
Emergent cesarean delivery is generally indicated for a viable fetus with severe persistent compromise unless vaginal delivery is imminent. Severe hemorrhage or maternal instability requires immediate delivery, with route determined by the fastest and safest maternal-fetal option. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
Is vaginal delivery appropriate after abruption-associated fetal demise?
Usually yes. Vaginal delivery is generally preferred because it avoids surgical bleeding risk in a patient prone to DIC; individualize for maternal instability, contraindications to vaginal birth, or concern for uterine rupture. PubMed+1PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
How should chronic placental abruption be monitored?
Evidence is limited. After initial observation, selected stable patients may undergo outpatient management with serial growth assessment and once- or twice-weekly NST or biophysical profile from diagnosis; use Dopplers for concurrent growth restriction or suspected fetal anemia. PubMedPubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
References
- - IIER - accessdata.fda.gov — www.accessdata.fda.gov · www.accessdata.fda.gov
- Device Registration and Listing Module System — www.access.fda.gov · www.access.fda.gov
- Application - Product Code Builder — www.accessdata.fda.gov · www.accessdata.fda.gov
- Managing hepatic complications of pregnancy — bmjopengastro.bmj.com · bmjopengastro.bmj.com
- Cardiovascular Management in Pregnancy | Circulation — www.ahajournals.org · www.ahajournals.org
- Chronic Hypertension in Pregnancy | Circulation — www.ahajournals.org · www.ahajournals.org
- Soluble Endoglin As a Marker for Preeclampsia, Its ... — www.ahajournals.org · www.ahajournals.org
- Update on the Use of Antihypertensive Drugs in Pregnancy — www.ahajournals.org · www.ahajournals.org
- advanced.onlinelibrary.wiley.com — advanced.onlinelibrary.wiley.com · advanced.onlinelibrary.wiley.com
- Solutio Placentae - an overview — www.sciencedirect.com · www.sciencedirect.com
- Abruptio placentae: Clinical management in nonacute cases — www.sciencedirect.com · www.sciencedirect.com
- Placental abruption leading to disseminated intravascular ... — www.sciencedirect.com · www.sciencedirect.com
- Maternal outcomes of placental abruption with intrauterine ... — obgyn.onlinelibrary.wiley.com · obgyn.onlinelibrary.wiley.com
- Etiology, clinical manifestations, and prediction of placental ... — obgyn.onlinelibrary.wiley.com · obgyn.onlinelibrary.wiley.com
- Risk Factor Profiles of Placental Abruption in First and Second Pregnancies: Heterogeneous Etiologies — www.sciencedirect.com · www.sciencedirect.com
- Women with a history of placental abruption: when in a ... — obgyn.onlinelibrary.wiley.com · obgyn.onlinelibrary.wiley.com
- The Risk Factors for Placental Abruption in Preeclamptic ... — obgyn.onlinelibrary.wiley.com · obgyn.onlinelibrary.wiley.com
- Placental abruption leading to disseminated intravascular coagulation: a clinical case and short review - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Placental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Placental Abruption - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- Placental abruption — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Interventions for treating placental abruption - PMC — pmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
- Placenta Previa - StatPearls - NCBI Bookshelf — www.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
- PubMed - NIH — pubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov